Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.85
Delayed Data
As of 11:20am ET
 +0.1499 / +8.82%
Today’s Change
1.48
Today|||52-Week Range
5.00
-6.57%
Year-to-Date

Today’s Trading

Previous close1.70
Today’s open1.85
Day’s range1.85 - 1.85
Volume600
Average volume (3 months)3,079
Market cap$20.2M
Dividend yield--
Data as of 11:20am ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+1.68%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.21

Competitors

 Today’s
change
Today’s
% change
EVOKEvoke Pharma Inc+0.28+8.43%
ATOSAtossa Genetics Inc+0.05+5.88%
BVXVBiondVax Pharmaceuti...-0.30-7.23%
NUINNutrastar Internatio...+0.10+17.15%
Data as of 3:10pm ET, 09/03/2015

Financials

Next reporting dateDecember 2, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Partner Offers